Cargando…
Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre
BACKGROUND: Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins associated with the postsynaptic membrane of the neuromuscular junction. Several drugs may trigger an exacerbation of the disease. Melatonin supplements are widely used for the treatment of insomnia as the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640643/ https://www.ncbi.nlm.nih.gov/pubmed/33148186 http://dx.doi.org/10.1186/s12883-020-01975-y |